PROTEINURIA
Clinical trials for PROTEINURIA explained in plain language.
Never miss a new study
Get alerted when new PROTEINURIA trials appear
Sign up with your email to follow new studies for PROTEINURIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for transplant patients: drug targets kidney damage
Disease control Recruiting nowThis study tests a drug called sparsentan in 20 adults who have protein in their urine after a kidney transplant due to IgA nephropathy or FSGS. Participants take one pill daily for 36 weeks to see if it safely lowers protein levels and protects kidney function. The goal is to co…
Matched conditions: PROTEINURIA
Phase: PHASE4 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 04:30 UTC
-
New drug combo aims to slow kidney disease in IgA patients
Disease control Recruiting nowThis study tests whether combining budesonide and ambrisentan can reduce protein in the urine and slow kidney function decline in people with IgA nephropathy, a chronic kidney disease. About 129 adults with mild to moderate kidney damage will receive both drugs for 36 weeks. The …
Matched conditions: PROTEINURIA
Phase: PHASE4 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated May 26, 2026 04:30 UTC
-
Phone app aims to slow kidney disease in young adults
Disease control Recruiting nowThis study tests whether a smartphone app can help doctors and young adults with chronic kidney disease (CKD) follow the latest treatment guidelines. The app provides reminders, education, and care recommendations to delay kidney disease progression. About 80 participants aged 16…
Matched conditions: PROTEINURIA
Phase: NA • Sponsor: St. James's Hospital, Ireland • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New combo therapy aims to calm immune attack on kidneys
Disease control Recruiting nowThis study tests whether combining two immune-suppressing drugs, rituximab and cyclosporine, can safely reduce protein leakage in the urine of people with membranous nephropathy, a kidney disease where the immune system damages kidney filters. About 30 adults with persistent prot…
Matched conditions: PROTEINURIA
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for kids with kidney disease: drug combo aims to cut protein leakage
Disease control Recruiting nowThis study tests whether adding finerenone to standard blood pressure medicines can reduce protein in the urine of children aged 6 months to 18 years with chronic kidney disease. About 219 participants will receive either finerenone or a placebo for 6 months. The goal is to see i…
Matched conditions: PROTEINURIA
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated May 20, 2026 12:08 UTC
-
New hope for kids with kidney disease: finerenone safety trial expands
Disease control Recruiting nowThis study looks at the long-term safety of adding finerenone to standard blood pressure medicines for children aged 1 to 18 with chronic kidney disease and proteinuria (protein in urine). About 100 kids who were in an earlier study will take finerenone for up to 18 months. Resea…
Matched conditions: PROTEINURIA
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New study seeks to unlock the secrets of childhood high blood pressure
Knowledge-focused Recruiting nowThis study looks at why some children with high blood pressure develop heart or kidney damage. Researchers will measure certain chemicals in the blood and urine of 125 children aged 7-18 with a new diagnosis of high blood pressure, as well as healthy children. The goal is to bett…
Matched conditions: PROTEINURIA
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 04:41 UTC
-
Scientists hunt for clues behind Post-Transplant protein leak
Knowledge-focused Recruiting nowThis study looks at why some kidney transplant patients, especially those with a kidney disease called FSGS, develop protein in their urine again after surgery. Researchers will analyze blood and kidney tissue samples taken before and after the transplant to find the root cause. …
Matched conditions: PROTEINURIA
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated May 18, 2026 12:03 UTC